Modification of fatty acids composition in erythrocytes lipids in arterial hypertension associated with dyslipidemia

Table 1 Clinical and biochemical characteristics of patients with arterial hypertension, M ± m

Parameters	Control group, n = 11	Patients with AH, n = 24
		1 group (without DLP), n = 16	2 group (with DLP), n = 18
Systolic arterial pressure, mmHg.	105 ± 2	***141 ± 2	***141 ± 1
Diastolic arterial pressure, mmHg	65 ± 2	***87 ± 1	***88 ± 1
TC, mmol/l	4,44 ± 0,21	4,33 ± 0,06	5,16 ± 0,13*
ТG, mmol/l	0,68 ± 0,07	**0,92 ± 0,04	*1,79 ± 0,14*
HDL, mmol/l	1,41 ± 0,11	1,29 ± 0,02	*0,97 ± 0,05*
LDL, mmol/l	2,72 ± 0,22	2,63 ± 0,06	*4,00 ± 0,06*
VLDL, mmol/l	0,31 ± 0,03	*0,4 ± 0,01	*0,65 ± 0,01*
AI, a.u.	2,27 ± 0,05	2,45 ± 0,08	*4,35 ± 0,09*

Note: tabl. 1, 2 (*) - Statistically significant differences linked to the control group are on the left, - for the 1group are on the right: * - p < 0.05, ** - p < 0.01, *** - p < 0,001.

ISSN: 1476-511X